Covered recipient · General Payments record
VICTOR JESUS TORRES-ORTIZ
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,577.20
- Reported across 63 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $470.46 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $230.79 | 9 |
| Medtronic, Inc. | $60.69 | 1 |
| GENZYME CORPORATION | $60.14 | 2 |
| Olympus Latin America, Inc. | $51.43 | 1 |
| Janssen Pharmaceuticals, Inc | $48.58 | 2 |
| Madrigal Pharmaceuticals | $18.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.40 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106234546 | CMS |
| ABBVIE INC. | $21.40 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106234548 | CMS |
| ABBVIE INC. | $29.87 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106234550 | CMS |
| ABBVIE INC. | $21.40 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106234552 | CMS |
| ABBVIE INC. | $32.19 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106234554 | CMS |
| ABBVIE INC. | $21.40 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106234556 | CMS |
| ABBVIE INC. | $32.96 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106234558 | CMS |
| ABBVIE INC. | $16.05 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106234560 | CMS |
| ABBVIE INC. | $34.12 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106234562 | CMS |
| GENZYME CORPORATION | $29.33 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139837573 | CMS |
| GENZYME CORPORATION | $30.81 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139837587 | CMS |
| Janssen Pharmaceuticals, Inc | $23.97 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078169171 | CMS |
| Janssen Pharmaceuticals, Inc | $24.61 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078169443 | CMS |
| Madrigal Pharmaceuticals | $18.83 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144183985 | CMS |
| Medtronic, Inc. | $60.69 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119430785 | CMS |
| Olympus Latin America, Inc. | $51.43 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099612431 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.